Citius Oncology (CTOR)
NASDAQ:CTOR
US Market
Holding CTOR?
Track your performance easily

Citius Oncology (CTOR) Technical Analysis

44 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
4Neutral
8Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Citius Oncology’s (CTOR) Moving Averages Convergence Divergence (MACD) indicator is -0.14, suggesting Citius Oncology is a Sell.
Citius Oncology’s (CTOR) 20-Day exponential moving average is 1.26, while Citius Oncology’s (CTOR) share price is $1.22, making it a Buy.
Citius Oncology’s (CTOR) 50-Day exponential moving average is 2.50, while Citius Oncology’s (CTOR) share price is $1.22, making it a Sell.

Citius Oncology (CTOR) Pivot Points

Nov 13, 2024, 11:20 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.93
1.05
1.20
1.32
1.47
1.59
1.74
Fibonacci
1.05
1.16
1.22
1.32
1.43
1.49
1.59
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Citius Oncology (CTOR) Moving Averages

Nov 13, 2024, 11:20 PM
Period
Simple
Exponential
MA5
1.27Buy
1.28Buy
MA10
1.21Buy
1.24Buy
MA20
1.20Buy
1.26Buy
MA50
1.35Sell
2.50Sell
MA100
6.64Sell
4.95Sell
MA200
8.89Sell
7.40Sell
Citius Oncology’s (CTOR) 10-Day exponential moving average is 1.24, while Citius Oncology’s (CTOR) share price is $1.22, making it a Buy.
Citius Oncology’s (CTOR) 100-Day exponential moving average is 4.95, while Citius Oncology’s (CTOR) share price is $1.22, making it a Sell.
Citius Oncology’s (CTOR) stock price is $1.22 and Citius Oncology’s (CTOR) 50-day simple moving average is 1.35, creating a Sell signal.
Citius Oncology’s (CTOR) stock price is $1.22 and Citius Oncology’s (CTOR) 100-day simple moving average is 6.64, creating a Sell signal.
Citius Oncology’s (CTOR) stock price is $1.22 and Citius Oncology’s (CTOR) 200-day simple moving average is 8.89, creating a Sell signal.

Citius Oncology (CTOR) Technical Indicators

Nov 13, 2024, 11:20 PM
Name
Value
Implied Action
RSI (14)
46.20
Neutral
STOCH (9,6)
71.74
Neutral
STOCHRSI (14)
71.15
Neutral
MACD (12,26)
-0.14
Sell
ADX (14)
9.76
Buy
Williams %R
-31.19
Buy
CCI (14)
136.56
Sell
ATR (14)
0.23
-
Ultimate Oscillator
47.54
Neutral
ROC
5.65
Buy
Citius Oncology’s (CTOR) Relative Strength Index (RSI) is 46.20, creating a Neutral signal.
Citius Oncology’s (CTOR) Trend Strength Indicator (ADX) is 9.76, creating a Buy signal.
Citius Oncology’s (CTOR) Commodity Channel Index (CCI) is 136.56, creating a Sell signal.
Citius Oncology’s (CTOR) Price Rate of Change (ROC) is 5.65, creating a Buy signal.

FAQ

Is CTOR a Buy, Hold, or Sell?
Based on CTOR’s technical indicators, CTOR is a Hold.
    What is CTOR’s RSI (14)?
    CTOR’s RSI (14) is 46.20, which suggests CTOR is a Neutral.
      What is CTOR’s MACD?
      CTOR’s MACD is -0.14, which suggests CTOR is a Sell.
        What is CTOR’s 5-day moving average?
        CTOR’s 5-day moving average is 1.27, which suggests CTOR is a Buy.
          What is CTOR’s 20-day moving average?
          CTOR 20-day moving average is 1.20, which suggests CTOR is a Buy.
            What is CTOR’s 50-day moving average?
            CTOR’s 50-day moving average is 1.35, which suggests CTOR is a Sell.
              What is CTOR’s 200-day moving average?
              CTOR’s 200-day moving average is 8.89, which suggests CTOR is a Sell.
                What is CTOR’s Williams % R (14)?
                CTOR’s Williams % R (14) is -31.19, which suggests CTOR is a Buy.
                  What is CTOR’s CCI (14)?
                  CTOR’s CCI (14) is 136.56, which suggests CTOR is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis